Trending Topic

6 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Grace Johanna Salazar Tamayo

Highlights Determining infection and multidrug resistance (MDR) rates continuously helps to detect the problem to be solved, including outbreaks. Cleaning and disinfection play an important role in preventing MDR and evaluating and correcting the process for better results. MDR control can only be achieved with various measures applied continuously and consistently by a group of […]

Avoiding Multidrug Resistance in a Hospital Setting

Grace Johanna Salazar Tamayo
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Published Online: Sep 25th 2024 touchREVIEWS in Infectious Diseases. 2024;3(1):Online ahead of journal publication
Select a Section…
1

Abstract

Overview

Avoiding multidrug resistance in hospitals is a challenging but achievable task that requires understanding local epidemiology and evaluating and intervening in cleaning and disinfection processes, antibiotic stewardship and prevention measures. These activities must be routinely evaluated and continuously applied, with executive directive management support and teamwork from infection committee members alongside active leaders of each process. An infographic on avoiding multidrug resistance in a hospital setting is available alongside this article here.

Keywords
2

Article

Highlights

  • Determining infection and multidrug resistance (MDR) rates continuously helps to detect the problem to be solved, including outbreaks.

  • Cleaning and disinfection play an important role in preventing MDR and evaluating and correcting the process for better results.

  • MDR control can only be achieved with various measures applied continuously and consistently by a group of committed individuals.

 

Development

Antimicrobial resistance is a global crisis. Approximately 1.3 million deaths were directly attributable to multidrug-resistant (MDR) microorganisms in 2019.1 These infections also have significant implications for hospital control and expenditure, as well as morbidity and mortality.2,3 MDR microorganisms can colonize a patient for months or years, and this colonized population can re-enter the community and potentially transmit this resistance.4,5

Controlling MDR in hospitals is crucial not only for reducing morbidity and mortality in hospitalized patients, but also for ensuring the quality of healthcare and reducing hospital costs.6

This task is challenging and involves multiple activities implemented simultaneously after a local epidemiological analysis, along with evaluating and providing feedback on the measures taken to identify the strengths and weaknesses of each hospital environment. These activities include the following:

  1. evaluating the epidemiological profile of community- and healthcare-associated infections (HAIs);

  2. assessing the hospital resistance profile;

  3. analysing antibiotic consumption;

  4. evaluating cleaning and disinfection processes:

  5. promoting hand hygiene; and

  6. implementing other measures.

Point 1: Evaluating the epidemiological profile of community- and healthcare-associated infections

This includes identifying the infections, causative microorganisms and susceptibility profiles reported as a value, for example, #/1,000 catheter days and #/1,000 ventilator days, which are evaluated over a specific period and are globally comparable.7,8 The reported frequency of MDR in HAIs varies between 25.4% and 42.5%, and these percentages vary in each hospital.9–11 Analysing the rates of infections and the frequency of MDR microorganisms and whether empirical antimicrobial use is appropriate in HAIs benefit the problem detection, including outbreaks. These data must be collected, evaluated and communicated continuously because it is the key to management decision-making.

Point 2: Assessing the hospital resistance profile

This involves identifying the most frequent MDR microorganisms and their distribution. In 2017, the World Health Organization published a list of critical priority pathogens. The most significant in hospitals include methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, extended-spectrum beta-lactamase (ESBL) Enterobacteriaceae, Enterobacterales, Clostridioides difficile (CD), carbapenem-resistant Acinetobacter baumanniiPseudomonas aeruginosa and Enterobacteriaceae.2,12 The distribution of MDR microorganisms varies in each hospital, region and continent.13,14 Identifying the most common MDR microorganisms in a hospital, the areas where they arise and their behaviour over time helps focus efforts on areas needing surveillance and control.

Point 3: Analysing antibiotic consumption

This includes evaluating antibiotic consumption with recommended measures.15,16 These data and the epidemiological profile help determine if there are alarming antibiotic consumption patterns, such as frequent carbapenem use in an intensive care unit, with only 3% ESBL isolates. Antimicrobial stewardship includes electronic pre-authorization systems or personnel providing feedback after prescriptions; this can encompass all or some antimicrobials and all or certain hospital areas. Involving each department’s staff in decision-making, protocol development and educational measures on prescribing is essential to achieving the main programme goal: changing antibiotic prescribing behaviour.15,17

Biochemist pharmacists should be included to report inappropriate antibiotic use and potentially lead the antimicrobial stewardship programme.18–20 The microbiology laboratory should standardize culture reports to guide physicians towards appropriate treatment decisions.21–23 Initially, programme goals should be defined, such as reducing CD rates or glycopeptide consumption, and compliance should be re-evaluated.

All available tools should be used to control antibiotics in the hospital through various interventions to improve antibiotic prescriptions.

Point 4: Evaluating the cleaning and disinfection process

None of the previous points will be effective without environmental control. Microorganisms can live on surfaces for weeks or months, potentially causing infections in hospitalized patients through horizontal transmission.24,25 Studies have shown that the risk of acquiring an MDR microorganism in a room previously occupied by a colonized patient is up to four times higher.26–28 Different cleaning and disinfection interventions have controlled MDR microorganism outbreaks, highlighting the importance of this process (see Table 1).29–33

Table 1: Outbreaks with different control and prevention interventions29–33

Study

Problem

Intervention in cleaning and disinfection

Other interventions

Main outcome

Ikeda et al.29

Outbreak of ESBL-producing bacteria in catheter-associated urinary tract infection in patients with spinal cord injury

Cleaning procedures were reviewed and the number of routine cleanings was increased using a complex-type chlorine-based disinfectant cleaner with potassium peroxymonosulphate

Environmental cultures once a week.

Periodical surveillance of urine cultures for patients who have undergone catheterization.

Nurses working in wards were educated on infection control, contact precautions and hand hygiene

Reduction to one ESBL-producing strain 1 month later

Zhu et al.30

Thirty-one patients with Klebsiella pneumoniae carbapenemase-2 and/or New Delhi Metallo-β-Lactamase 1 K. pneumoniae strains in 10 different wards in a 2,076-bed tertiary care teaching hospital

Antimicrobial stewardship workers enhanced disinfection of the patient’s room at least three times a day; after discharge, the surroundings were cleaned in depth using a 500-ppm chlorine solution and high-touch surfaces were emphasized by the hospital hygiene nurse manager for cleaning to reduce cross-transmission

Set up a working group on the antimicrobial stewardship.

Strict infection control procedures were put in place, including rapid communication, suggestions on rational drug use in time and training courses, contact precautions of carriers, surveillance cultures of the hand and environment and screening for all contact patients

Return to the epidemiological stage with sporadic occurrence of carbapenem-resistant K. pneumoniae strains

Gavaldá et al.31

Increase in new cases of extensively drug-resistant (XDR) Acinetobacter baumannii after a period of high endemicity

To agree on the specific responsibilities and allocation of cleaning duties of the auxiliary nurses and housekeepers; deep environmental cleaning after a staggered schedule; increasing the cleaning frequency of high-touch surfaces; apply ready-to-use disinfectant wipes with cationic surfactant tensioactives, quaternary ammonium compounds and polymeric biguanide by auxiliary nurses and microfibre cleaning system containing 0.1% chlorine solution by housekeepers with the one-room, one-wipe approach

A multidisciplinary task force was established to determine the main control strategies; rectal swabs from patients admitted to the intensive care units

The implementation of interventions was associated with a significant change in the level of -8,360 XDR A. baumannii-infected patients per 1,000 patient days

Grabsch et al.32

Markedly increased colonized patients on active screening of ‘high-risk’ wards (intensive care unit and renal, liver transplant and haematology-oncology units) and VRE bacteraemia

Replacement of surface cleaning/disinfection compounds with sodium hypochlorite 1,000 ppm + detergent; employment of cleaning supervisors and establishment of a formal training programme for cleaning staff; implementation of a thrice-annual schedule detailed bleach-based ‘super-clean-disinfection’

Adherence to the Centers for Disease Control and Prevention VRE guidelines for managing patients with colonization

Significant reductions in newly recognized colonized VRE (208/1,948 patients screened versus 324/4,035, a 24.8% reduction); the total burden of inpatients with VRE declined; median percentage of colonized inpatients per week: 19.4% versus 17.3%; hospital-wide VRE bacteraemia declined 83.1%

Salazar et al.33

Increase in CRE strains in a general hospital

Training to cleaning and disinfection staff twice a year; monthly supervisions of the cleaning and disinfection process with a checklist, reviewing for the cleanliness of surfaces with alcohol wipes, and analysed the processes

Full management support for all decisions related to infection control; blinded observation of hand hygiene with monthly evaluations, disseminating the data to sensitize health personnel; restrictive antimicrobial stewardship; active surveillance of healthcare infections and contact isolation of carries in a specific area

Decrease in the CRE rate: 0.59 versus 0.18 cases/1,000 patient days

CRE = carbapenem-resistant Enterobacteriaceae; ESBL = extended-spectrum beta-lactamase; VRE = vancomycin-resistant enterococci; XDR = extensively drug-resistant.

First, the process should be observed: how it is conducted and if basic principles and recommended frequencies are applied with correct materials and dilutions.34,35 Disinfectants should meet international standards, and selection should be based on local epidemiology.28,30 Possible barriers, such as toxicity data, difficult dilutions, application methods and communication challenges that limit process compliance, should also be evaluated.36,37 For well-resourced institutions, non-touch technologies are advantageous.38–40 However, hospitals with fewer resources must consider human and material limitations. Frequent supervision of the process is also crucial: both observational and objective with methods, such as adenosine triphosphate bioluminescence, along with feedback and periodic update training.36,41,42

Point 5: Promoting hand hygiene

The importance of adherence to hand hygiene in infection control is undeniable.43–45 Every hospital should monitor hand hygiene adherence, disseminate these data and promote it. There is electronic technology that monitors product use and/or free electronic tools that consolidate hand hygiene observation data.46,47

Point 6: Other measures

In certain contexts, the contact isolation of patients colonized or infected with MDR microorganisms is questionable, but it remains a recommended measure by the Centers for Disease Control and Prevention.48–50 Contact isolation should be applied according to the epidemiological profile and hospital resources, educating staff on the use of personal protective equipment.

Other measures influencing MDR identification include protocols for detecting colonized patients, the use of skin-decolonizing agents and the emergence and study of outbreaks.51 Equally important is having sufficient, permanent and trained staff for patient care, especially in critical areas, to prevent horizontal transmission, as well as infrastructure that allows individual patient rooms in some hospitals versus shared spaces where contamination is more likely.52–54

Although the importance of MDR control is globally recognized, not all countries have mandatory regulatory standards for hospital control. It is essential to know local regulations that support infection control interventions and request financial, human and technological support from executive directive management, considering cost–benefit and savings analyses.55–57

Conclusion

MDR is a global threat, and its control is vital in hospitals. This control must be achieved through multiple measures (stewardship programme, improved cleaning and disinfection, adherence to hand hygiene, contact isolation and detection of colonized patients, among others) adopted after an epidemiological analysis that identifies frequent microorganisms and infections in hospital and through a working group that includes every actor from executive directive management to cleaning and disinfection staff, all fulfilling defined roles in evaluating, educating and continuously providing feedback on all MDR control processes in the hospital.

3

References

List View
Grid View
1
Copy DOIDOI Copied
Visit DOI Link

 Antimicrobial Resistance CollaboratorsGlobal burden of bacterial antimicrobial resistance in 2019: A systematic analysisLancet2022;399:62955DOI10.1016/S0140-6736(21)02724-0.

2
Copy DOIDOI Copied
Visit DOI Link

 Siegel JRhinehart EJackson Met alManagement of multidrug-resistant organisms in healthcare settings, 20062006Available atwww.cdc.gov/infection-control/hcp/mdro-management/index.html (Date last accessed15 February 2017).

3
Copy DOIDOI Copied
Visit DOI Link

 Cassini AHögberg LDPlachouras DBurden of AMR Collaborative GroupAttributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysisLancet Infect Dis2019;19:5666DOI10.1016/S1473-3099(18)30605-4.

4
Copy DOIDOI Copied
Visit DOI Link

 Zimmerman FSAssous MVBdolah-Abram Tet alDuration of carriage of carbapenem-resistant Enterobacteriaceae following hospital dischargeAm J Infect Control2013;41:1904DOI10.1016/j.ajic.2012.09.020.

5
Copy DOIDOI Copied
Visit DOI Link

 Riccio MEVerschuuren TConzelmann Net alHousehold acquisition and transmission of extended-spectrum Β-lactamase (ESBL)-producing enterobacteriaceae after hospital discharge of ESBL-positive index patientsClin Microbiol Infect2021;27:13229DOI10.1016/j.cmi.2020.12.024.

6
Copy DOIDOI Copied
Visit DOI Link

 Gidey KGidey MTHailu BYet alClinical and economic burden of healthcare-associated infections: A prospective cohort studyPLoS One2023;18:e0282141DOI10.1371/journal.pone.0282141.

7
Copy DOIDOI Copied
Visit DOI Link

 National Healthcare Safety NetworkBloodstream infection event (central line-associated bloodstream infection and non-central line associated bloodstream infection) 2024Available atwww.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf (Date last accessed8 August 2024).

8
Copy DOIDOI Copied
Visit DOI Link

 National Healthcare Safety NetworkPneumonia (ventilator-associated [VAP] and non-ventilator-associated pneumonia [PNEU] event) 2024Available atwww.cdc.gov/nhsn/pdfs/pscmanual/6pscvapcurrent.pdf (Date last accessed8 August 2024).

9
Copy DOIDOI Copied
Visit DOI Link

 Wang MWei HZhao Yet alAnalysis of multidrug-resistant bacteria in 3223 patients with hospital-acquired infections (HAI) from a tertiary general hospital in ChinaBosn J Basic Med Sci2019;19:8693DOI10.17305/bjbms.2018.3826.

10
Copy DOIDOI Copied
Visit DOI Link

 Cornejo-Juárez PVilar-Compte DPérez-Jiménez Cet alThe impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unitInt J Infect Dis2015;31:314DOI10.1016/j.ijid.2014.12.022.

11
Copy DOIDOI Copied
Visit DOI Link

 Jiang A-MShi XLiu Net alNosocomial infections due to multidrug-resistant bacteria in cancer patients: A six-year retrospective study of an oncology center in Western ChinaBMC Infect Dis2020;20:452DOI10.1186/s12879-020-05181-6.

12
Copy DOIDOI Copied
Visit DOI Link

 World Health Organization (WHO)Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis 2017Available atwww.who.int/publications/i/item/WHO-EMP-IAU-2017.12 (Date last accessed8 August 2024).

13
Copy DOIDOI Copied
Visit DOI Link

 European Centre for Disease Prevention and Control and World Health Organization European RegionAntimicrobial resistance surveillance in Europe 2023 – 2021 data. 2023Available atwww.ecdc.europa.eu/sites/default/files/documents/Antimicrobial%20resistance%20surveillance%20in%20Europe%202023%20-%202021%20data.pdf (Date last accessed8 August 2024).

14
Copy DOIDOI Copied
Visit DOI Link

 Seas CGarcia CSalles MJet alLatin America Working Group on Bacterial ResistanceStaphylococcus aureus bloodstream infections in Latin America: Results of a multinational prospective cohort studyJ Antimicrob Chemother2018;73:21222DOI10.1093/jac/dkx350.

15
Copy DOIDOI Copied
Visit DOI Link

 World Health Organization. Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries. A WHO Practical Toolkit2019Available athttps://iris.who.int/bitstream/handle/10665/329404/9789241515481-eng.pdf?sequence=1 (Date last accessed8 August 2024).

16
Copy DOIDOI Copied
Visit DOI Link

 Barlam TFCosgrove SEAbbo LMet alImplementing an antibiotic stewardship program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of AmericaClin Infect Dis2016;62:e5177DOI10.1093/cid/ciw118.

17
Copy DOIDOI Copied
Visit DOI Link

 WHO Regional Office for Europe. Antimicrobial stewardship interventions: A practical guide2021Available athttps://iris.who.int/bitstream/handle/10665/340709/9789289054980-eng.pdf (Date last accessed8 August 2024).

18
Copy DOIDOI Copied
Visit DOI Link

 Cantudo-Cuenca MRJiménez-Morales AMartínez-de la Plata JEPharmacist-led antimicrobial stewardship programme in a small hospital without infectious diseases physiciansSci Rep2022;12:9501DOI10.1038/s41598-022-13246-6.

19
Copy DOIDOI Copied
Visit DOI Link

 Abdelrahman DHAbuSara AKKhabour DSThe impact of pharmacist-led antimicrobial stewardship review of cultures in the ambulatory setting at a comprehensive cancer centerHosp Pharm2023;58:3925DOI10.1177/00185787221150920.

20
Copy DOIDOI Copied
Visit DOI Link

 Jantarathaneewat KCamins BApisarnthanarak AThe role of the clinical pharmacist in antimicrobial stewardship in Asia: A reviewAntimicrob Steward Healthc Epidemiol2022;2:e176DOI10.1017/ash.2022.310.

21
Copy DOIDOI Copied
Visit DOI Link

 Coupat CPradier CDegand Net alSelective reporting of antibiotic susceptibility data improves the appropriateness of intended antibiotic prescriptions in urinary tract infections: A case-vignette randomised studyEur J Clin Microbiol Infect Dis2013;32:62736DOI10.1007/s10096-012-1786-4.

22
Copy DOIDOI Copied
Visit DOI Link

 Wang YZhang XZhou QXu XImpact of selective reporting of antimicrobial susceptibility testing report on clinicians’ prescribing behavior of antibioticsFront Pharmacol2023;14:1225531DOI10.3389/fphar.2023.1225531.

23
Copy DOIDOI Copied
Visit DOI Link

 Lestin-Bernstein FHarberg RSchumacher Iet alStaphylococcus aureus – Selective reporting of antibiogram results and its impact on antibiotic use: Interventional study with a reference group on the effect of switching from non-selective to selective antibiotic reportingAntimicrob Resist Infect Control2021;10:157DOI10.1186/s13756-021-01021-7.

24
Copy DOIDOI Copied
Visit DOI Link

 Porter LSultan OMitchell BGet alHow long do nosocomial pathogens persist on inanimate surfaces? A scoping reviewJ Hosp Infect2024;147:2531DOI10.1016/j.jhin.2024.01.023.

25
Copy DOIDOI Copied
Visit DOI Link

 Sood GPerl TMOutbreaks in health care settingsInfect Dis Clin North Am2016;30:66187DOI10.1016/j.idc.2016.04.003.

26
Copy DOIDOI Copied
Visit DOI Link

 Drees MSnydman DRSchmid CHet alPrior environmental contamination increases the risk of acquisition of vancomycin-resistant EnterococciClin Infect Dis2008;46:67885DOI10.1086/527394.

27
Copy DOIDOI Copied
Visit DOI Link

 Nseir SBlazejewski CLubret Ret alRisk of acquiring multidrug-resistant gram-negative Bacilli from prior room occupants in the intensive care unitClin Microbiol Infect2011;17:12018DOI10.1111/j.1469-0691.2010.03420.x.

28
Copy DOIDOI Copied
Visit DOI Link

 Shaughnessy MKMicielli RLDePestel DDet alEvaluation of hospital room assignment and acquisition of Clostridium difficile infectionInfect Control Hosp Epidemiol2011;32:2016DOI10.1086/658669.

29
Copy DOIDOI Copied
Visit DOI Link

 Ikeda YShigemura KNomi Met alInfection control following an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated from catheter-associated urinary tract infectionJpn J Infect Dis2018;71:15861DOI10.7883/yoken.JJID.2017.330.

30
Copy DOIDOI Copied
Visit DOI Link

 Zhu JLi QLi Xet alSuccessful control of the first carbapenem-resistant Klebsiella pneumoniae outbreak in a Chinese hospital 2017–2019Antimicrob Resist Infect Control2020;9:91DOI10.1186/s13756-020-00757-y.

31
Copy DOIDOI Copied
Visit DOI Link

 Gavaldà LSoriano AMCámara Jet alControl of endemic extensively drug-resistant Acinetobacter baumannii with a cohorting policy and cleaning procedures based on the 1 room, 1 wipe approachAm J Infect Control2016;44:5204DOI10.1016/j.ajic.2015.11.036.

32
Copy DOIDOI Copied
Visit DOI Link

 Grabsch EAMahony AACameron DRMet alSignificant reduction in vancomycin-resistant Enterococcus colonization and Bacteraemia after introduction of a bleach-based cleaning-disinfection programmeJ Hosp Infect2012;82:23442. DOI10.1016/j.jhin.2012.08.010.

33
Copy DOIDOI Copied
Visit DOI Link

 Salazar Tamayo GJCastelo Vigme JPPeralta Prado ABet alHow to avoid multidrug resistance (MDR)? successful experience with the application of a hospital bundle (HB)Presented atECCMID 2023Copenhagen, Denmark Available athttps://elibrary.escmid.org/?search%5Bfrom%5D=0&search%5Bquery%5D=%22Grace;%22&search%5Bcategory%5D%5B0%5D=8&search%5Bdate%5D=&tab=docs#results.

34
Copy DOIDOI Copied
Visit DOI Link

 Rutala WAWeber DJHealthcare Infection Control Practices Advisory Committee (HICPAC)Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008. Available atwww.cdc.gov/infection-control/media/pdfs/Guideline-Disinfection-H.pdf (Date last accessed8 August 2024).

35
Copy DOIDOI Copied
Visit DOI Link

 Rutala WAWeber DJDisinfection and sterilization in health care facilities: What clinicians need to knowClin Infect Dis2004;39:7029DOI10.1086/423182.

36
Copy DOIDOI Copied
Visit DOI Link

 Assadian OHarbarth SVos Met alPractical recommendations for routine cleaning and disinfection procedures in healthcare institutions: A narrative reviewJ Hosp Infect2021;113:10414DOI10.1016/j.jhin.2021.03.010.

37
Copy DOIDOI Copied
Visit DOI Link

 Rutala WAWeber DJSterilization, high-level disinfection, and environmental cleaningInfect Dis Clin North Am2011;25:4576DOI10.1016/j.idc.2010.11.009.

38
Copy DOIDOI Copied
Visit DOI Link

 Dancer SJControlling hospital-acquired infection: Focus on the role of the environment and new technologies for decontaminationClin Microbiol Rev2014;27:66590DOI10.1128/CMR.00020-14.

39
Copy DOIDOI Copied
Visit DOI Link

 Scott RJoshi LTMcGinn CHospital surface disinfection using ultraviolet germicidal irradiation technology: A reviewHealthc Technol Lett2022;9:2533DOI10.1049/htl2.12032.

40
Copy DOIDOI Copied
Visit DOI Link

 Boyce JMModern technologies for improving cleaning and disinfection of environmental surfaces in hospitalsAntimicrob Resist Infect Control2016;5:10DOI10.1186/s13756-016-0111-x.

41
Copy DOIDOI Copied
Visit DOI Link

 Public Health Ontario. Best practices for environmental cleaning for prevention and control of infections in all health care settings, 3rd edition2018Available atwww.publichealthontario.ca/-/media/documents/B/2018/bp-environmental-cleaning.pdf (Date last accessed8 August 2024).

42
Copy DOIDOI Copied
Visit DOI Link

 Smith PWBeam ESayles Het alImpact of adenosine triphosphate detection and feedback on hospital room cleaningInfect Control Hosp Epidemiol2014;35:5649DOI10.1086/675839.

43
Copy DOIDOI Copied
Visit DOI Link

 Pittet DHugonnet SHarbarth Set alEffectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection control programmeLancet2000;356:130712DOI10.1016/s0140-6736(00)02814-2.

44
Copy DOIDOI Copied
Visit DOI Link

 Kingston LO’Connell NHDunne CPHand hygiene-related clinical trials reported since 2010: A systematic reviewJ Hosp Infect. 2016;92:30920. DOI10.1016/j.jhin.2015.11.012.

45
Copy DOIDOI Copied
Visit DOI Link

 Marimuthu KPittet DHarbarth SThe effect of improved hand hygiene on nosocomial MRSA controlAntimicrob Resist Infect Control2014;3:34DOI10.1186/2047-2994-3-34.

46
Copy DOIDOI Copied
Visit DOI Link

 Allegranzi BGayet-Ageron ADamani Net alGlobal implementation of WHO’s multimodal strategy for improvement of hand hygiene: A quasi-experimental studyLancet Infect Dis2013;13:84351DOI10.1016/S1473-3099(13)70163-4.

47
Copy DOIDOI Copied
Visit DOI Link

 Wang CJiang WYang Ket alElectronic monitoring systems for hand hygiene: Systematic review of technologyJ Med Internet Res2021;23:e27880DOI10.2196/27880.

48
Copy DOIDOI Copied
Visit DOI Link

 Kelly GHudson MApple Bet alDiscontinuation of contact precautions in patients with hospital-acquired MRSA and VRE infections during the COVID-19 pandemic: A multi-center experienceJ Infect Prev2024;25:337DOI10.1177/17571774231208312.

49
Copy DOIDOI Copied
Visit DOI Link

 Gottlieb LBWalits EPatel GSchaefer STaking off the gown: Impact of discontinuing contact precautions for extended-spectrum β-lactamase (ESBL)-producing organismsAntimicrob Steward Healthc Epidemiol2021;1:e31DOI10.1017/ash.2021.189.

50
Copy DOIDOI Copied
Visit DOI Link

 Siegel JDRhinehart EJackson Met al2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings Available atwww.cdc.gov/infection-control/media/pdfs/Guideline-Isolation-H.pdf (Date last accessed8 August 2024).

51
Copy DOIDOI Copied
Visit DOI Link

 Tien KLWang JTSheng WHet alChlorhexidine bathing to prevent healthcare-associated vancomycin-resistant Enterococcus infections: A cluster quasi-experimental controlled study at intensive care unitsJ Formos Med Assoc2021;120:101421DOI10.1016/j.jfma.2020.08.048.

52
Copy DOIDOI Copied
Visit DOI Link

 Stone PWPogorzelska MKunches Let alHospital staffing and health care-associated infections: A systematic review of the literatureClin Infect Dis2008;47:93744DOI10.1086/591696.

53
Copy DOIDOI Copied
Visit DOI Link

 Wang RXia JZhao Set alThe advantages of single-room management in an ICU and the changing trend of drug-resistant bacteria over the last 5 yearsIntensive Care Res2023;3:1829DOI10.1007/s44231-023-00028-5.

54
Copy DOIDOI Copied
Visit DOI Link

 Halaby TAl Naiemi NBeishuizen Bet alImpact of single room design on the spread of multi-drug resistant bacteria in an intensive care unitAntimicrob Resist Infect Control2017;6:117DOI10.1186/s13756-017-0275-z.

55
Copy DOIDOI Copied
Visit DOI Link

 Bryant KAHarris ADGould CVet alNecessary infrastructure of infection prevention and healthcare epidemiology programs: A reviewInfect Control Hosp Epidemiol2016;37:37180DOI10.1017/ice.2015.333.

56
Copy DOIDOI Copied
Visit DOI Link

 Benenson SCohen MJSchwartz Cet alIs it financially beneficial for hospitals to prevent nosocomial infections?BMC Health Serv Res2020;20:653DOI10.1186/s12913-020-05428-7.

57
Copy DOIDOI Copied
Visit DOI Link

 Xiong CLWang GGHanafi WUFinancial impact of nosocomial infections on surgical patients in an eastern Chinese hospital: A propensity score matching studyJ Hosp Infect2023;139:6773DOI10.1016/j.jhin.2023.05.017.

4

Article Information

Disclosure

Grace Johanna Salazar Tamayo has no financial or non-financial relationships or activities to declare in relation to this article.

Compliance With Ethics

This article is an opinion piece and does not report on new clinical data, or any studies with human or animal subjects performed by any of the authors.

Review Process

Double-blind peer review.

Authorship

The named author meets the International Committee of Medical Journal Editors (ICMJE) criteria for authorship of this manuscript, takes responsibility for the integrity of the work as a whole, and has given final approval for the version to be published.

Correspondence

Grace Johanna Salazar TamayoInfection control and preventionAxxis HospitalQuitoEcuador CP 170401grace.salazar@gmail.com

Support

No funding was received in the publication of this article.

Access

This article is freely accessible at touchINFECTIOUSDISEASES.com. ©Touch Medical Media 2024.

Acknowledgements

This article is published with an infographic to enhance understanding, which was peer reviewed alongside the manuscript. To view the infographic, please see via www.touchinfectiousdiseases.com here.

Data Availability

Data sharing is not applicable to this article as no datasets were generated or analysed during the writing of this article.

Received

2023-12-13

5

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Close Popup